NEW YORK (GenomeWeb News) – Manchester, UK-based Tepnel Life Sciences today said that the Illinois Department of Public Health has selected its Elucigene CF-US test for two-stage testing of cystic fibrosis under a newly mandated screening program for all newborns in the state.
Tepnel’s test is designed for use on high-throughput capillary sequencers and detects 44 mutations in the cystic fibrosis transmembrane conductance regulator gene and their wild-type counterparts.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.